Tag: Stem Cells
AAD: Skin Videomicroscopy Biomarker May Help Predict Cancer Relapse
Assessment of leukocytes adherent to and rolling along vessel wall may help predict outcomes after HCT for hematologic cancer
Frailty Mars Outcomes After aHSCT in Lymphoid Malignancies
Links found for frailty with in-hospital mortality, prolonged length of stay for patients with NHL, HL, MM undergoing aHSCT
Survival Increase Seen for Adults With Relapsed Ph+ ALL
From 2000 to 2019, overall survival progressively improved for patients with Philadelphia-positive ALL who had posttransplant relapse
FDA Approves Livtencity for Posttransplant Cytomegalovirus
Livtencity is indicated for posttransplant CMV that does not respond to available antiviral treatments
ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease
The use of HSCT for sickle cell disease is evolving, and no randomized controlled trials were identified in the evidence review for this guideline
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
Overall response, failure-free survival, symptom response significantly greater with ruxolitinib versus control therapy
Stem Cell Transplant Reviewed for Peripheral T-Cell Lymphoma
Three- and five-year overall survival similar with allogeneic or autologous HSCT, but transplant-related mortality higher with allogeneic HSCT
Gene Therapy Promising for SCID Due to ADA Deficiency
High overall, event-free survival seen at 24 and 36 months for severe combined immunodeficiency due to ADA deficiency
Biden Administration Lifts Restrictions on Medical Research Using Fetal Tissues
All projects that had been approved before the Trump administration restrictions 'will be reinstated without further review'
Stem Cell Transplant May Slow Disability in Multiple Sclerosis
Long-term outcomes assessed in 210 patients with MS who underwent autologous hematopoietic stem cell transplantation
